Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy
- Benjamin W. Fischer-Valuck
- , Jeff M. Michalski
- , Joanna G. Harton
- , Alison Birtle
- , John P. Christodouleas
- , Jason A. Efstathiou
- , Vivek K. Arora
- , Eric H. Kim
- , Eric M. Knoche
- , Russell K. Pachynski
- , Joel Picus
- , Yuan James Rao
- , Melissa Reimers
- , Bruce J. Roth
- , Paul Sargos
- , Zachary L. Smith
- , Mohamed S. Zaghloul
- , Hiram A. Gay
- , Sagar A. Patel
- , Brian C. Baumann
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Department of Radiation Oncology
- Section of Medical Oncology
- Division of Urologic Surgery
- Division of Clinical Research
- Bursky Center for Human Immunology and Immunotherapy
- Section of Molecular Oncology & Developmental Therapeutics
- Division of Veterans Affairs
- DBBS - Molecular Cell Biology
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Immunology
- Mentorship to Enhance Development in Academia Program
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
4
Link opens in a new tab
Scopus
citations